Stefano Espinoza
Cited by
Cited by
Dopamine receptors–IUPHAR R eview 13
JM Beaulieu, S Espinoza, RR Gainetdinov
British journal of pharmacology 172 (1), 1-23, 2015
Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats
D Leo, I Sukhanov, F Zoratto, P Illiano, L Caffino, F Sanna, G Messa, ...
Journal of Neuroscience 38 (8), 1959-1972, 2018
Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor
S Espinoza, A Salahpour, B Masri, TD Sotnikova, M Messa, LS Barak, ...
Molecular pharmacology 80 (3), 416-425, 2011
Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors
D Leo, L Mus, S Espinoza, MC Hoener, TD Sotnikova, RR Gainetdinov
Neuropharmacology 81, 283-291, 2014
BRET biosensors to study GPCR biology, pharmacology, and signal transduction
A Salahpour, S Espinoza, B Masri, V Lam, LS Barak, RR Gainetdinov
Frontiers in endocrinology 3, 105, 2012
TAAR1 modulates cortical glutamate NMDA receptor function
S Espinoza, G Lignani, L Caffino, S Maggi, I Sukhanov, D Leo, L Mus, ...
Neuropsychopharmacology 40 (9), 2217-2227, 2015
The dopamine metabolite 3-methoxytyramine is a neuromodulator
TD Sotnikova, JM Beaulieu, S Espinoza, B Masri, X Zhang, A Salahpour, ...
PloS one 5 (10), e13452, 2010
Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1
S Espinoza, V Ghisi, M Emanuele, D Leo, I Sukhanov, TD Sotnikova, ...
Neuropharmacology 93, 308-313, 2015
Insights into the Structure and Pharmacology of the Human Trace Amine‐Associated Receptor 1 (hTAAR1): Homology Modelling and Docking Studies
E Cichero, S Espinoza, RR Gainetdinov, L Brasili, P Fossa
Chemical biology & drug design 81 (4), 509-516, 2013
Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases
MD Schwartz, JJ Canales, R Zucchi, S Espinoza, I Sukhanov, ...
Expert opinion on therapeutic targets 22 (6), 513-526, 2018
SINEUP non-coding RNA targeting GDNF rescues motor deficits and neurodegeneration in a mouse model of Parkinson’s disease
S Espinoza, M Scarpato, D Damiani, F Manag˛, M Mereu, A Contestabile, ...
Molecular Therapy 28 (2), 642-652, 2020
Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists
G Chiellini, G Nesi, M Digiacomo, R Malvasi, S Espinoza, M Sabatini, ...
Journal of Medicinal Chemistry 58 (12), 5096-5107, 2015
Trace amine-associated receptor 5 provides olfactory input into limbic brain areas and modulates emotional behaviors and serotonin transmission
S Espinoza, I Sukhanov, EV Efimova, A Kozlova, KA Antonova, P Illiano, ...
Frontiers in molecular neuroscience 13, 18, 2020
Long-term optical stimulation of channelrhodopsin-expressing neurons to study network plasticity
G Lignani, E Ferrea, F Difato, J Amar¨, E Ferroni, E LugarÓ, S Espinoza, ...
Frontiers in molecular neuroscience 6, 22, 2013
Increased context-dependent conditioning to amphetamine in mice lacking TAAR1
I Sukhanov, L Caffino, EV Efimova, S Espinoza, TD Sotnikova, L Cervo, ...
Pharmacological research 103, 206-214, 2016
Further Insights Into the Pharmacology of the Human Trace Amine‐Associated Receptors: Discovery of Novel Ligands for TAAR 1 by a Virtual Screening Approach
E Cichero, S Espinoza, S Franchini, S Guariento, L Brasili, ...
Chemical biology & drug design 84 (6), 712-720, 2014
TAAR1-dependent effects of apomorphine in mice
I Sukhanov, S Espinoza, DS Yakovlev, MC Hoener, TD Sotnikova, ...
International Journal of Neuropsychopharmacology 17 (10), 1683-1693, 2014
Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies
M Tonelli, S Espinoza, RR Gainetdinov, E Cichero
European Journal of Medicinal Chemistry 127, 781-792, 2017
In-vivo pharmacology of trace-amine associated receptor 1
VM Lam, S Espinoza, AS Gerasimov, RR Gainetdinov, A Salahpour
European journal of pharmacology 763, 136-142, 2015
Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy
MJ Polanco, S Parodi, D Piol, C Stack, M Chivet, A Contestabile, ...
Science Translational Medicine 8 (370), 370ra181-370ra181, 2016
The system can't perform the operation now. Try again later.
Articles 1–20